Covid19
Conditions
Brief summary
Mixed-methods process evaluation of a residence-based asymptomatic SARS-CoV-2 testing participation pilot
Detailed description
Regular testing for SARS Coronavirus 2 (SARS-CoV-2) is an important strategy for controlling virus outbreaks on university campuses during the COVID-19 pandemic but testing participation rates can be low. The Residence-Based Testing Participation Pilot (RB-TPP) was a novel intervention implemented at two student residences on a large university campus in the UK over four weeks. The aim of the pilot was to increase the frequency of asymptomatic SARS-CoV-2 saliva testing onsite. This process evaluation aimed to determine whether RB-TPP was implemented as planned and identify implementation barriers and facilitators. A mixed-methods process evaluation was conducted alongside the RB-TPP. Evaluation participants were students (who opted in, or out of the RB-TPP) and staff with a role in service provision or student support. Monitoring data were collected from the intervention delivery team and meeting records. Data were collected from students via an online survey (n=152) and seven focus groups (n=30), and from staff via individual interviews (n=13). Quantitative data were analysed descriptively and qualitative data thematically.
Interventions
SARS-CoV-2 asymptomatic saliva testing (as available to all students at staff at the participating university) delivered with relaxed social distancing (behavioural element) in two halls of residence.
Sponsors
Study design
Masking description
N/A process evaluation, single group intervention
Intervention model description
Process evaluation of a SARS-CoV-2 testing participation uptake scheme in a single group of students living in two halls of residence.
Eligibility
Inclusion criteria
* Student is living in one of the two participating halls of residence. * staff with operational or student support role. * consents to participate.
Exclusion criteria
* Student is not living in the hall of residence at the start of the RB-TPP. * does not consent to participate.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Reach | 1 week | Program reach was evaluated through the number of students recruited into the RB-TPP compared to the number of potentially eligible students living in one of the two participating sites in April 2021 |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Adherence | 4 weeks | Participant adherence was defined as the proportion of students who completed all tests offered. |
| Dose | 4 weeks | Number of tests offered |
| Generalised Anxiety Disorders Scale (Spitzer et al., 2006; Kroenke et al., 2007). | 4 weeks | A 7-item anxiety scale with good reliability, as well as criterion, construct, factorial, and procedural validity. A cut point of \>=10 indicates moderate to severe anxiety. Higher scores indicate higher anxiety. |
| Student Focus Groups | 4 weeks | Student's views towards the RB-TPP. Small group discussions lasting approximately 60 mins conducted at mid-point and/or programme end. |
| Staff interviews | 4 weeks | Staff views towards the RB-TPP. Individual interviews lasting approximately 20-60 mins conducted at programme end. |
Countries
United Kingdom